Skip Navigation Links
Skip Navigation Links


MATCH: Molecular analysis for therapy choice. Targeted therapy directed by genetic testing in treating patients with advanced refractory solid tumors or lymphoma. EAY131 (NCT02465050)  (MBMC Contact: Missy Kuhn 314-996-5868) 

Androgen deprivation therapy and high dose radiotherapy with or without whole pelvic radiotherapy in unfavorable intermediate or favorable high risk prostate cancaer:  A phase III randomized trial
 NRG RTOG 0924 (NCT01368588)  (MBMC Contact Missy Kuhn 314-996-5868)

Prostate Cancer Trials in St. Louis, MO

All contents 2007 Heartland Cancer Research St. Louis, MO. All rights reserved. Privacy Policy